STOCK COMPARISON
Dolby Laboratories vs Cintas: Fair Value & Quality
Both stocks run through our valuation models. Here is how Dolby Laboratories (DLB) and Cintas (CTAS) compare, as of Aug 10, 2026.
As of Aug 10, 2026, Fair Value Calculator sees Dolby Laboratories as the less overvalued of the two: Dolby Laboratories trades at $61.77 versus a fair value of $52.32 (-15%), while Cintas trades at $203 versus $95.30 (-53%).
Dolby Laboratories
DLB · USD · Information Technology
-15%
upside to fair value
overvalued
Price$61.77
Fair Value$52.32
Quality77/100
Cintas
CTAS · USD · Industrials
-53%
upside to fair value
overvalued
Price$203
Fair Value$95.30
Quality78/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Dolby LaboratoriesCintas
Valuation
19.5×P/E (TTM)42.0×
3.40×P/S (TTM)7.33×
1.77×P/B16.06×
10.9×EV/EBITDA27.0×
2.08×PEG3.06×
2.8%Dividend yield—
$1.41Dividend per share$1.74
Profitability
18%Net margin18%
29%Operating margin24%
9%Return on equity41%
5%Return on assets16%
Growth
7%Revenue growth (YoY)9%
2.5%Avg. growth/yr (3Y)8.5%
3.0%Avg. growth/yr (5Y)9.6%
Balance & size
—Debt / equity0.47×
$5BMarket cap$83B
healthyGrowth qualityhealthy
Dolby Laboratories leads: 7 to 5 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Dolby Laboratoriesof which business quality 76 · market factors 45
Cintasof which business quality 74 · market factors 53
ProfitabilityMargins and returns on capital today
53
91
Quality GrowthAre margins and returns improving?
39
53
CashflowEarnings quality: real cash, not paper profit
96
67
Fin. StrengthBalance sheet, leverage, solvency risk
95
70
InvestmentDisciplined investing over empire-building
79
71
Low VolatilityCalm price path (market factor)
73
74
MomentumPrice trend over the last 3–12 months (market factor)
32
44
52W MomentumDistance to the 52-week high (market factor)
35
45
Net IssuanceBuybacks instead of dilution
88
90
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Dolby Laboratories
DCF Models$104
Earnings-Based$37.29
Dividend Discount$32.92
Multiples$78.18
Asset-Based$29.12
Growth DCF$104
Economic Profit$46.84
Growth Earnings$73.62
9 of 26 models see the stock below the current price.
Cintas
DCF Models$96.89
Earnings-Based$48.67
Dividend Discount$30.85
Multiples$76.91
Asset-Based$8.61
Growth DCF$74.33
Economic Profit$58.94
Growth Earnings$81.35
26 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Dolby Laboratories
Bear $39.24Fair Value $52.32Bull $65.40
$61.77 = current price (white tick)
Cintas
Bear $56.44Fair Value $95.30Bull $121
$203 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Dolby Laboratories · Information Technology
Quality score77 · Top 25%
Fair value upside-15% · above median
Cintas · Industrials
Quality score78 · Top 25%
Fair value upside-53% · below median
Bottom line
As of Aug 10, 2026, Fair Value Calculator sees Dolby Laboratories as the less overvalued of the two: Dolby Laboratories trades at $61.77 versus a fair value of $52.32 (-15%), while Cintas trades at $203 versus $95.30 (-53%).
Cintas has the higher quality score (78/100).
See the full analysis →
More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Free · Top-25 report
See the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
